[Trial of a combination of proscillaridin A, thioridazine and Cori ester in the ambulatory treatment of some cardiopathies, especially senile types].
The effect of an association of proscillaridin A, thioridazine and Cori ester in ambulatory management of certain heart diseases, particularly in aged subjects, was assessed. Satisfactory results were observed in 58.3% of cases, with significant improvement of cardiac erethism, psychomotor instability and sleep disturbances, as well as cardiac frequency and signs of myocardial insufficiency. It is felt that the association is of assistance in the treatment of certain heart diseases unaccompanied by frank signs of insufficiency, especially in aged subjects.
D000368:Aged; D002018:Bufanolides / Q000627:therapeutic use*; D003327:Coronary Disease / Q000188:drug therapy; D004338:Drug Combinations; D005260:Female; D005958:Glucosephosphates / Q000627:therapeutic use*; D006331:Heart Diseases / Q000188:drug therapy*; D006333:Heart Failure / Q000188:drug therapy; D006349:Heart Valve Diseases / Q000188:drug therapy; D006801:Humans; D006973:Hypertension / Q000150:complications; D008297:Male; D008875:Middle Aged; D011442:Proscillaridin / Q000627:therapeutic use*; D011660:Pulmonary Heart Disease / Q000188:drug therapy; D013881:Thioridazine / Q000627:therapeutic use*
D002018:Bufanolides; D004338:Drug Combinations; D005958:Glucosephosphates; D011442:Proscillaridin; D013881:Thioridazine
Sperimentazione di una associazione di proscillaridina A, tioridazina ed estere di Cori nel trattamento ambulatoriale di alcune cardiopatie in particolare senili